{
    "Trade/Device Name(s)": [
        "LIAISON Ferritin",
        "LIAISON\u00ae Ferritin",
        "LIAISON \u2297 Ferritin"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K193650",
    "Predicate Device Reference 510(k) Number(s)": [
        "K971833"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBF"
    ],
    "Summary Letter Date": "March 16, 2021",
    "Summary Letter Received Date": "March 17, 2021",
    "Submission Date": "September 13, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.5340"
    ],
    "Regulation Name(s)": [
        "Ferritin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Ferritin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Serum separator tubes (SST)",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum separator tube (SST)",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "LIAISON XL Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON Ferritin chemiluminescent immunoassay for quantitative ferritin measurement using LIAISON XL Analyzer",
    "Indications for Use Summary": "Quantitative automated chemiluminescent immunoassay for in vitro detection of ferritin in human serum, SST, or lithium heparin plasma to aid diagnosis of iron deficiency anemia and iron overload",
    "fda_folder": "Immunology"
}